1. Home
  2. ANL vs GOOD Comparison

ANL vs GOOD Comparison

Compare ANL & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$9.36

Market Cap

611.1M

Sector

N/A

ML Signal

HOLD

Logo Gladstone Commercial Corporation Real Estate Investment Trust

GOOD

Gladstone Commercial Corporation Real Estate Investment Trust

HOLD

Current Price

$12.61

Market Cap

607.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANL
GOOD
Founded
2004
2003
Country
United States
United States
Employees
109
72
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
611.1M
607.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ANL
GOOD
Price
$9.36
$12.61
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$20.00
$12.50
AVG Volume (30 Days)
144.9K
597.2K
Earning Date
04-10-2026
05-05-2026
Dividend Yield
N/A
9.54%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$36.02
$9.89
Revenue Next Year
N/A
$2.57
P/E Ratio
N/A
$62.41
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$10.33
52 Week High
$17.25
$14.65

Technical Indicators

Market Signals
Indicator
ANL
GOOD
Relative Strength Index (RSI) 40.75 55.53
Support Level $9.46 $12.19
Resistance Level $9.98 $12.92
Average True Range (ATR) 1.35 0.26
MACD 0.05 0.03
Stochastic Oscillator 27.46 82.32

Price Performance

Historical Comparison
ANL
GOOD

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About GOOD Gladstone Commercial Corporation Real Estate Investment Trust

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

Share on Social Networks: